Wound model of myocardial infarction

American Journal of Physiology - Heart and Circulatory Physiology

Volumn 288, Issue 3 57-3, 2005, Pages

  Ertl, Georg ^a   Frantz, Stefan ^a  

^a UNIVERSITY OF WÜRZBURG   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ANGIOTENSIN 1 RECEPTOR; ANGIOTENSIN 1 RECEPTOR ANTAGONIST; CAPTOPRIL; COLLAGEN; DARUSENTAN; DIPEPTIDYL CARBOXYPEPTIDASE; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; ENDOTHELIN A RECEPTOR ANTAGONIST; GLYCERYL TRINITRATE; HORMONE; MATRIX METALLOPROTEINASE; NEUROHORMONE; PROTEINASE; SECRETORY LEUKOCYTE PROTEINASE INHIBITOR;

CLINICAL TRIAL; COLLAGEN SYNTHESIS; COLLATERAL CIRCULATION; CORONARY ARTERY DILATATION; CORONARY ARTERY OBSTRUCTION; CORONARY STENT; DRUG EFFECT; DRUG EFFICACY; EDITORIAL; ENZYME ACTIVITY; HEART DILATATION; HEART FAILURE; HEART INFARCTION; HEART INFARCTION SIZE; HEART LEFT VENTRICLE HYPERTROPHY; HEART LEFT VENTRICLE VOLUME; HEART MUSCLE NECROSIS; HEART MUSCLE REPERFUSION; HEART VENTRICLE REMODELING; HUMAN; INFLAMMATORY CELL; ISCHEMIC HEART DISEASE; MYOFIBROBLAST; NONHUMAN; PATHOPHYSIOLOGY; PRIORITY JOURNAL; PROGNOSIS; SCAR FORMATION; TISSUE REPAIR; TISSUE STRUCTURE;

EID: 13944271026     PISSN: 03636135     EISSN: None     Source Type: Journal    
DOI: 10.1152/ajpheart.00977.2004     Document Type: Editorial

References (23)

1. Aikawa Y, Rohde L, Plehn J, Greaves SC, Menapace F, Arnold MO, Rouleau JL, Pfeffer MA, Lee RT, and Solomon SD. Regional wall stress predicts ventricular remodeling after anteroseptal myocardial infarction in the Healing and Early Afterload Reducing Trial (HEART): an echocardiography-based structural analysis. Am Heart J 141: 234-242, 2001.
2. Ashcroft GS, Lei K, Jin W, Longenecker G, Kulkarni AB, Greenwell-Wild T, Hale-Donze H, McGrady G, Song XY, and Wahl SM. Secretory leukocyte protease inhibitor mediates non-redundant functions necessary for normal wound healing. Nat Med 6: 1147-1153, 2000.
3. Bart BA, Ertl G, Held P, Kuch J, Maggioni AP, McMurray J, Michelson EL, Rouleau JL, Warner Stevenson L, Swedberg K, Young JB, Yusuf S, Sellers MA, Granger B, Califf RM, and Pfeffer MA. Contemporary management of patients with left ventricular systolic dysfunction. Results from the Study of Patients Intolerant of Converting Enzyme Inhibitors (SPICE) Registry. Eur Heart J 20: 1182-1190, 1999.
4. Blankesteijn WM, Creemers E, Lutgens E, Cleutjens JP, Daemen MJ, and Smits JF. Dynamics of cardiac wound healing following myocardial infarction: observations in genetically altered mice. Acta Physiol Scand 173: 75-82, 2001.
5. Boyle MP and Weisman HF. Limitation of infarct expansion and ventricular remodeling by late reperfusion. Study of time course and mechanism in a rat model. Circulation 38: 2872-2883, 1993.
6. Force T, Kemper A, Leavitt M, and Parisi AF. Acute reduction in functional infarct expansion with late coronary reperfusion: assessment with quantitative two-dimensional echocardiography. J Am Coll Cardiol 11: 192-200, 1988.
7. Fraccarollo D, Galuppo P, Bauersachs J, and Ertl G. Collagen accumulation after myocardial infarction: effects of ETA receptor blockade and implications for early remodeling. Cardiovasc Res 54: 559-567, 2002.
8. Gaudron P, Eilles C, Kugler I, and Ertl G. Progressive left ventricular dysfunction and remodeling after myocardial infarction: potential mechanisms and early predictors. Circulation 87: 755-763, 1993.
9. Gaudron P, Hu K, Schamberger R, Budin M, Walter B, and Ertl G. Effect of endurance training early or late after coronary artery occlusion on left ventricular remodeling, hemodynamics, and survival in rats with chronic transmural myocardial infarction. Circulation 89: 402-412, 1994.
10. Gudbjarnason S, Fenton JC, Wolf PL, and Bing RJ. Stimulation of reparative processes following experimental myocardial infarction. Arch Intern Med 118: 33-40, 1966.
11. Hale SL and Kloner RA. Left ventricular topographic alterations in the completely healed rat infarct caused by early and late coronary artery reperfusion. Am Heart J 116: 1508-1513, 1988.
12. Hochman JS and Choo H. Limitation of myocardial infarct expansion by reperfusion independent of myocardial salvage. Circulation 75: 299-306, 1987.
13. Holbrook KA and Byers PH. Skin is a window on heritable disorders of connective tissue. Am J Med Genet 34: 105-121, 1989.
14. A antagonist EMD94246 in rats with experimental myocardial infarction. J Cardiovasc Pharmacol 32: 505-508, 1998.
15. Ichihara S, Senbonmatsu T, Price E Jr, Ichiki T, Gaffney FA, and Inagami T. Targeted deletion of angiotensin II type 2 receptor caused cardiac rupture after acute myocardial infarction. Circulation 106: 2244-2249, 2002.
16. Jeremy MW, Hackworthy RA, Bautovich G, Button BF, and Harris PJ. Infarct artery perfusion and changes in left ventricular volume in the month after acute myocardial infarction. J Am Coll Cardiol 9: 989-995, 1987.
17. Jugdutt BI. Effect of nitroglycerin and ibuprofen on left ventricular topography and rupture threshold during healing after myocardial infarction in the dog. Can J Physiol Pharmacol 66: 385-395, 1988.
18. Jugdutt BI, Khan MI, Jugdutt SJ, and Blinston GE. Impact of left ventricular unloading after late reperfusion of canine anterior myocardial infarction on remodeling and function using isosorbide-5-mononitrate. Circulation 92: 926-934, 1995.
19. Nguyen T, El Salibi E, and Rouleau JL. Postinfarction survival and inducibility of ventricular arrhythmias in the spontaneously hypertensive rat: effects of ramipril and hydralazine. Circulation 98: 2074-2080, 1998.
20. Pfeffer MA, McMurray JJ, Velazquez EJ, Rouleau JL, Køber L, Maggioni AP, Solomon SD, Swedberg K, Van de Werf F, White H, Leimberger JD, Henis M, Edwards S, Zelenkofske S, Sellers MA, Califf RM; Valsartan in Acute Myocardial Infarction Trial Investigators. Valsartan, captopril, or both in myocardial infarction complicated by heart failure, left ventricular dysfunction, or both. N Engl J Med 349: 1893-906, 2003.
21. A-receptor blockade prevents matrix metalloproteinase activation late postmyocardial infarction in the rat. Am J Physiol Heart Circ Physiol 280: H984-H991, 2001.
22. Yu CM, Tipoe GL, Wing-Hon Lai K, and Lau CP. Effects of combination of angiotensin-converting enzyme inhibitor and angiotensin receptor antagonist on inflammatory cellular infiltration and myocardial interstitial fibrosis after acute myocardial infarction. J Am Coll Cardiol 38: 1207-1215, 2001.
23. Zdrojewski T, Gaudron P, Whittaker P, Poelzl S, Schiemann J, Hu K, and Ertl G. Ventricular remodeling after myocardial infarction and effects of ACE inhibition on hemodynamics and scar formation in SHR. Cardiovasc Pathol 11: 88-93, 2002.